SMO and asthma: These findings provide molecular insights into the interaction between Hedgehog signalling and Th17 differentiation, highlighting Smo and GLI3 as potential therapeutic targets for corticosteroid-resistant asthma driven by Th17 cells (Jin et al., 2024).